Tata Elxsi Share Price: Terumo ke saath AI Tech Centre launch, Stock **4.81%** Bhaga!

TECH
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Tata Elxsi Share Price: Terumo ke saath AI Tech Centre launch, Stock **4.81%** Bhaga!
Overview

Bhai log, Tata Elxsi ke stock mein aaj badhiya tezi dikhi! Company ne Terumo Corporation ke liye ek naya Global Offshore Development Center (ODC) khola hai jo AI aur advanced engineering use karega. Is deal ke baad share seedha **4.81%** upar chala gaya.

Dekho toh, Tata Elxsi ne Terumo ke saath milkar ek naya Global Offshore Development Center (ODC) launch kiya hai. Ye centre Terumo ke cardiac aur vascular solutions ko improve karne ke liye advanced engineering aur AI use karega. Isse Tata Elxsi ko medical device aur healthcare IT outsourcing ke badhte market mein entry milegi, jo bahut achha sign hai.

Is khabar ke chalte Friday ko Tata Elxsi ka share 4.81% badhkar ₹4,233.70 par trade hua, aur din mein toh ₹4,253.30 tak pahunch gaya! Lagbhag 0.26 million shares ka volume dekha gaya, jiski value ₹111 crore thi. Company ki market cap ab ₹26,332.18 crore ho gayi hai.

Ab agar valuation ki baat karein, toh Tata Elxsi ka P/E ratio 40-50x ke aas paas rehta hai, jo TCS (18-19x), Infosys (17-18x), Wipro (15-16x) aur HCL Tech (21-22x) jaise bade players se kaafi zyada hai. Ye premium valuation investor confidence dikhata hai ki company specialised areas jaise automotive aur healthcare mein acha kaam kar sakti hai. Analysts ko lagta hai ki healthcare IT outsourcing market $150.13 billion tak aur medical device outsourcing market $50.44 billion tak grow karega (between 2024 and 2028), jisse Tata Elxsi ko fayda hoga.

Lekin bhai, sabhi analysts itne khush nahi hain. Kuch ne caution bhi jataya hai. Jaise Ambit Capital ne September 2024 mein 'Sell' rating di thi, unka kehna hai ki growth slow hokar 11.2% ho jayegi (FY24-27), jo pehle 17.4% (FY20-24) thi. Iska ek bada reason hai Jaguar Land Rover (JLR) par zyadatar dependency, jisne FY24 mein 74% incremental revenue diya tha. Axis Capital ne July 2025 mein bhi 'Sell' kiya tha, unke according JLR ke alawa company ka performance kamzor hai aur margins bhi gir rahe hain FY22 se FY25 ke beech. Stock ka 47x P/E ratio ye batata hai ki market expectations bahut high hain, aur thodi si bhi galti ya client concentration ka issue dikha toh dikkat ho sakti hai.

Par haan, kuch analysts positive bhi hain. Incred Equities ne December 2025 mein isko 'Hold' rating di hai, unhe transportation sector mein visibility aachi lag rahi hai aur margins bhi improve hone ke signs hain. Average analyst target price lagbhag ₹5,008 hai, matlab abhi thoda aur upar jaane ka scope hai. Company AI aur GenAI par bhi dhyan de rahi hai, jaise automotive ke liye DevStudio.ai platform. Healthcare market mein bhi bade opportunities hain, jo Tata Elxsi ke liye achhi khabar hai.

Disclaimer:This content is for informational purposes only and does not constitute financial or investment advice. Readers should consult a SEBI-registered advisor before making decisions. Investments are subject to market risks, and past performance does not guarantee future results. The publisher and authors are not liable for any losses. Accuracy and completeness are not guaranteed, and views expressed may not reflect the publication’s editorial stance.